Skip to content

Myocardial Oedema in ST Segment Elevation Myocardial Infarction Myocardial

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01897350
Enrollment
30
Registered
2013-07-12
Start date
2013-07-31
Completion date
Unknown
Last updated
2014-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Oedema, ST Segment Elevation Myocardial Infarction

Keywords

STEMI, Myocardial edema, Cardiovascular magnetic resonance

Brief summary

Cardiac magnetic resonance imaging (CMR) is a non invasive technique used to obtain functional and anatomical information on the heart. Several CMR parameters measured after primary percutaneous coronary intervention (PPCI) have been shown to have prognostic value and are increasingly being used as surrogate endpoints in clinical trials. Myocardial oedema is a prognostic indicator following myocardial infarction1. Myocardial salvage is calculated as the myocardial oedema minus infarct size; this again is a prognostic indicator following STEMI. However, myocardial oedema imaging is controversial. There are multiple sequences available, with no standardisation of sequences used to assess this surrogate endpoint. The investigators propose to conduct a study to measure the myocardial oedema by all available techniques to determine the agreement between these methods.

Interventions

OTHERCardiac magnetic resonance imaging

Sponsors

Elisa McAlindon
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* STEMI * providing written informed consent

Exclusion criteria

* contraindication to CMR, * atrial fibrillation, * claustrophobia, * eGFR \< 30

Design outcomes

Primary

MeasureTime frame
The mass of myocardial oedema measured by CMRDay 2 following STEMI

Secondary

MeasureTime frame
Extra cellular volumeDay 2 following STEMI

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026